Zinda Michael has filed 16 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 5611 shares of Repare Therapeutics Inc. ($RPTX) on March 12, 2025.
Activity breakdown: 0 open-market purchases and 9 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2025 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 5611 | $1.14 | 80,297.0000 | 42,411,085 | 6.53% | 0.01% |
| March 4, 2025 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Shares | 14000 | $0.00 | 85,908.0000 | 42,411,085 | 19.47% | 0.03% |
| March 4, 2025 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 42,411,085 | 9999.99% | 0.18% |
| March 4, 2025 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 42,411,085 | 9999.99% | 0.20% |
| March 28, 2024 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 450 | $4.64 | 72,318.0000 | 42,093,293 | 0.62% | 0.00% |
| April 1, 2024 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 410 | $4.66 | 71,908.0000 | 42,093,293 | 0.57% | 0.00% |
| March 25, 2024 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 450 | $4.78 | 73,668.0000 | 42,093,293 | 0.61% | 0.00% |
| March 26, 2024 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 450 | $4.61 | 73,218.0000 | 42,093,293 | 0.61% | 0.00% |
| March 27, 2024 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S | Common Shares | 450 | $4.62 | 72,768.0000 | 42,093,293 | 0.61% | 0.00% |
| March 1, 2024 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Common Shares | 14000 | $0.00 | 74,118.0000 | 42,093,293 | 23.29% | 0.03% |
| March 1, 2024 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 42,093,293 | 9999.99% | 0.20% |
| June 7, 2023 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, Chief Scientific Officer | S | Common Shares | 6404 | $12.03 | 62,987.0000 | 0 | 9.23% | 0.00% |
| June 8, 2023 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, Chief Scientific Officer | S | Common Shares | 2869 | $12.02 | 60,118.0000 | 0 | 5.01% | 0.00% |
| June 6, 2023 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, Chief Scientific Officer | S | Common Shares | 1200 | $12.04 | 69,391.0000 | 0 | 1.70% | 0.00% |
| Jan. 30, 2023 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, Chief Scientific Officer | A | Common Shares | 24550 | $0.00 | 70,591.0000 | 0 | 53.32% | 0.00% |
| Jan. 30, 2023 | Repare Therapeutics Inc. | $RPTX | Zinda Michael | EVP, Chief Scientific Officer | A | Employee Stock Option (right to buy) | 97100 | $0.00 | 97,100.0000 | 0 | 9999.99% | 0.00% |